Speaking of Mol Bio27 Jan 2023

CRISPR | Making the world better

Since it’s discovery, CRISPR Cas9 gene editing technology has blossomed and boomed. It’s moved from a highly technical niche technique to one that is arguably mainstream and being applied to countless challenges in applied biology. In this episode we talk with Travis Hardcastle, who previously worked in R&D to develop gene editing products and is now a Product Manager for Engineered Cell Lines at Synthego. Travis helps explain the basics of gene editing and how it’s being applied to cell line engineering and provides a well-informed perspective on the past, present, and future of the CRISPR revolution. This conversation touches on automation, bioproduction, and the feedback loop of guide DNA and cell line development. The therapeutic application of this technology, which has the potential to truly enable personalized medicine, is a focal point of this personal and informative conversation.

Tune in today. Subscribe to get future episodes. Share with a friend or colleague that might enjoy too!

Visit thermofisher.com/molbioschool to access molecular biology resources and educational content.

Experience the Speaking of Mol Bio podcast in its extended video format for a more immersive journey, while also ensuring accessibility with downloadable transcripts for each episode.

Watch now at thermofisher.com/podcast-video

Subscribe to get future episodes as they drop and if you like what you’re hearing we hope you’ll share a review or recommend the series to a colleague. 

Visit the Invitrogen School of Molecular Biology to access helpful molecular biology resources and educational content, and please share this resource with anyone you know working in molecular biology.

For Research Use Only. Not for use in diagnostic procedures.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(54)

The tools, stories, and science behind Absolute Gene-ius

Molecular biology is more than a set of techniques. It is a toolkit for asking better questions. In this special crossover episode of Speaking of Mol Bio, Steve Lewis welcomes Jordan Ruggieri, Senior ...

8 Jul 26min

CRISPR, MPRA, and the genetics of mental health

Some genetic variants may help explain why different psychiatric disorders share overlapping biology. In this episode of Speaking of Mol Bio, host Steve Lewis speaks with Jess McAfee, PhD, and Alejand...

24 Jun 30min

From prototype to production – solving the scale-up gap

Great science doesn’t always translate into a scalable product, and that gap can stall even the most promising innovations. In this Mol Bio Minutes episode, Steve Lewis explores a common challenge in ...

10 Jun 7min

The real cost of PCR - beyond price per reaction

Not all experiments are created equal, and neither are the decisions behind them. In this episode, Cam Cyr explores how scientists navigate the balance between cost and performance in molecular biolog...

27 Mai 30min

The molecular toolkit behind HIV research

HIV research is one of the clearest examples of molecular biology in action. In this Mol Bio Minutes episode, Dr. Ryan Jeep walks through how fundamental molecular techniques power everything from det...

13 Mai 14min

DNA-encoded library use in living cells for drug discovery

In this episode of Speaking of Mol Bio, host Steve Lewis speaks with Dr. Leif Larsen, Director of Biology at Vipergen, about the power of DNA-encoded libraries (DELs) in modern drug discovery. DEL tec...

22 Apr 30min

Choosing the right PCR method for your experiment

In this Mol Bio Minutes mini-episode of Speaking of Mol Bio, Dr. Andrea Hunger walks listeners through the practical differences between three core PCR approaches: endpoint PCR, quantitative PCR (qPCR...

8 Apr 13min

From bench to bushland ─ developing a koala chlamydia vaccine

In this Season 4 premiere of Speaking of Mol Bio, host Steve Lewis speaks with Dr. Nina Pollak from the University of the Sunshine Coast about the development of a single-dose vaccine aimed at protect...

25 Mar 36min